FUTURES: Optogenetics – Light Switch of Memory

By: Estefania Gatton

Memories

Maybe the brain is an archive we possess that refuses to organize its files. In the two years since he left this world behind, my mind had become a museum of echoes. His sudden passing left me not just with grief, but with what I believed was neurological malfunction. I lived in a constant state of immediate past; every room I walked into was still occupied by the ghost of laughter, and every silence was a deafening reminder of a life planned to build.

My therapist called it a trauma-induced synaptic loop. I called it a prison. I could recite the physics of a black hole, but I could not explain how the orbit of my life continued to circle a center that had vanished. That was when I heard about the “Lumina Project.” In the era of high-end neuro-engineering, there was talk of a breakthrough therapy that didn’t just talk about trauma but physically rewrote the topography of the pain. It was called Ocular Neural Modulation, or as they said, the Light Bridge.

After thinking about it for a long, long time, discussing and talking with my friends, family, the cat in the 4th street… I finally traveled to the facility in the cloudy mountains, a place that felt more like a laboratory than a clinic. They didn’t ask me to recount my childhood. They didn’t ask me to cry if I wanted to. They only asked for the signature of my grief.

The procedure was a blend of myth and machinery. They mapped the precise coordinates of my hippocampal pathways, the physical geography where the memory of him lived, still. They explained that my grief was a “hyper-synchronized circuit.” My brain had become addicted to the intensity of the trauma, firing the same neural pathways every time I thought of him, creating a chemical feedback loop every time I went by my favorite specialty coffee shop where we met.

They prepared to introduce a temporary light-sensitive protein into the circuit, a biological veil that would respond to a specific wavelength of light. Then came the Light Bridge. A microscopic optic probe, thinner than a strand of hair, was lowered into the darkness of my skull.

When they switched on the source, it was the sensation of a cold, tight knot in my chest slowly untying. The light was a soft, pulsating purple, looking near to my favorite color of the sunsets of spring; a frequency tuned to disrupt the hyperactive firing of my mourning. I watched the monitors as my neural patterns leveled out. The violent peaks of my sorrow smoothed into rolling hills.

For the first time in twenty-four months, the ghost in the room vanished. The memories were still there, but the agony of the memory had been uncoupled. The Light Bridge hadn’t erased my emotions; it had merely disconnected the alarm that had been ringing in my soul all this time.

I left the clinic a few days later, stepping out into a world that finally looked present and real. Feeling every breath, the air smelled of rain and grass. I went to that coffee shop, and for the first time, I didn’t feel the weight of a world-ending loss. I felt the quiet, steady heartbeat my own life returning. And I sipped my coffee, tasted like achachairú. And the trauma was no longer the director of my internal cinema; it was just a file in the archive, stored safely on a shelf, no longer burning the pages.

From Fiction to Science

For decades, the field of neuroscience was defined by a daunting truth: the brain is an exquisitely complex electrical circuit, yet the tools available to interact with it were remarkably blunt instruments (1). Traditional stimulation methods, such as electrodes, activate all cells in their vicinity indiscriminately, often leading to low spatial resolution and significant interference with simultaneous recording (2). While pharmacological interventions offered a degree of receptor specificity, they acted too slowly to capture the millisecond-scale mechanism of neuronal firing (1). The neurobiology field dream was to gain control over specific sets of neurons, that were defined not just by their location, but by their genetic identity, to observe the direct effects on behavior and health in different organisms (3).

The conceptual foundation for this dream began decades ago with the discovery that certain microorganisms produce proteins that regulate ion flow in response to light. Bacteriorhodopsin was identified as a light-activated proton pump as early as 1971 (4). However, it was not until 2005 that this biological curiosity was transformed into a revolutionary control technology known as “optogenetics” (5). By merging optical precision with genetic engineering, scientists can now render specific neurons responsive to light. This was a breakthrough so profound that in 2010, it was named “Method of the Year” across all branches of science (6).

Rewriting Memory

One of the most remarkable applications of optogenetics is the ability to manipulate memory traces. In 2013, researchers famously succeeded in implanting a “false memory” in a mouse (7). By tagging the specific ensemble of neurons active while a mouse explored a neutral room and later reactivating those neurons with light while the mouse received a mild shock in a different environment, they created a memory of fear in a place where the animal had never been harmed (8). Even more strikingly, optogenetics have been used to retrieve “lost” memories. Research into infantile amnesia, the rapid forgetting of early childhood experiences, revealed that these memories are not permanently erased but rather become inaccessible due to retrieval failure. By optogenetically stimulating the neurons that originally encoded these infant memories, scientists were able to bring them back into adult mice (9). Similar techniques have retrieved “lost” memories in mouse models of early-stage Alzheimer’s disease, suggesting that dementia related forgetting may initially be a failure of the brain’s retrieval machinery rather than a loss of stored information (10, 11).

Clinical Revolutions

Optogenetics is rapidly moving from basic research into clinical frontiers, offering hope for previously intractable conditions. For instance, in Parkinson’s disease movement is disrupted by an imbalance in the motor circuits of the basal ganglia, optogenetics has been used to selectively activate the direct pathway or inhibit the indirect pathway, identifying the exact circuit nodes that can instantly rescue motor function and halt tremors in animal models (12). Moreover, in restoring vision, the first successful human clinical application occurred in 2021. A 58-year-old man, after 40 years of blindness due to retinitis pigmentosa, received an injection of a light-sensitive protein into his eye. By using specialized goggles to translate visual data into light pulses, he was able to perceive, count, and touch objects for the first time in decades (13). Furthermore, for treatment-resistant epilepsy, optogenetics offers on-demand control, where light pulses can instantly silence overactive neurons to stop a seizure. In pain management, silencing specific pain-sensing fibers in the spinal cord has effectively alleviated chronic and neuropathic pain in animal studies (14).

Psychiatric Applications

Optogenetics has fundamentally shifted psychiatric research from a descriptive science into a causal discipline. By manipulating specific neural circuits, researchers can identify the exact pathways responsible for complex mental health conditions. Let’s analyze the case of Depression. In psychiatric research, optogenetics have revealed the critical role of the medial prefrontal cortex and the ventral tegmental area in depression. In rodent models, the optical reactivation of hippocampal neurons associated with positive reward experiences has been shown to rescue stress-induced depression-like behaviors (15). Interestingly, while optical stimulation of these “positive engrams” suppressed depressive behavior, natural exposure to rewarding experiences sometimes failed to do so, highlighting a potential therapeutic target for anhedonia (16), that is the inability to feel joy from things you usually like. Research into schizophrenia has focused on gamma oscillations and high-frequency rhythms that coordinate information processing. Subjects with schizophrenia often show a reduction in parvalbumin-positive interneurons, which are essential for generating these oscillations. Optogenetic control of these interneurons has demonstrated that activating these cells can drive gamma oscillations and enhance cortical performance by reducing “circuit noise” (17).

The Ethics of Optogenetics

Like any other scientific tool, the power to edit memories or manipulate behavior comes with significant ethical responsibility (18). This has birthed the debate over “neurorights”, that could be defined as the fundamental right to mental integrity and personal identity (19). Critics point out that optogenetics involve irreversible genetic modification of neurons (20). For instance, if we can edit memories of trauma, do we risk depriving individuals of the redemption sequence, the personal growth and self-transformation that often follows suffering?. Furthermore, there are concerns that memory-erasing technologies could be exploited to silence whistleblowers or alter the testimonies of witnesses (18). As we master the ability to engineer brain circuits, we must simultaneously create a legal and ethical framework to protect the essence of human identity.

Conclusions

Ultimately, the development of optogenetics represents a fundamental transition in our relationship with the human brain. We have moved from being passive observers of our own neurological processes to becoming active designers of our internal landscapes and connections. As we advance in the optogenetics field, we are essentially reclaiming the power to rewrite the stories that define our existence and how we behave. The trajectory of research suggests that we are closer than ever to a new era of neuro-engineering. In the future, the goal of science is not to replace the human spirit, but to provide the tools necessary to understand the human brain.

References

1. Fiala, A., Suska, A., & Schlüter, O. M. (2010). Optogenetic approaches in neuroscience. Current biology : CB, 20(20), R897–R903. https://doi.org/10.1016/j.cub.2010.08.053 
2. Shirai, F., & Hayashi-Takagi, A. (2017). Optogenetics: Applications in psychiatric research. Psychiatry and clinical neurosciences, 71(6), 363–372. https://doi.org/10.1111/pcn.12516
3. Deisseroth, K., Feng, G., Majewska, A.K., Miesenbo¨ck, G., Ting, A., and Schnitzer, M.J. (2006). Next-generation optical technologies for illuminating genetically targeted brain circuits. J. Neurosci. 26, 10380–10386.
4. Oesterhelt, D., & Stoeckenius, W. (1971). Rhodopsin-like protein from the purple membrane of Halobacterium halobium. Nature: New biology, 233(39), 149–152. https://doi.org/10.1038/newbio233149a0
5. Boyden E et al. Millisecond-Timescale, Genetically Targeted Optical Control of Neural Activity. Nat Neu rosci. 2005;8, 1263-1268. doi:10.1038/nn1525.
6. Deisseroth K. “Optogenetics”. Nat Meth ods.2011;8(1): 26–9.doi:10.1038/n meth.f.324.
7. Ramirez S, Liu X, Lin P-A, Suh J, Pignatelli M, Redondo RL, RyanTJ,TonegawaS(2013)Creating a false memory in the Hippocampus. Science 341(6144):387–391. https://doi.org/10.1126/science.1239073
8. OishiN,NomotoM,OhkawaN, SaitohY, SanoY, Tsujimura S, Nishizono H, Matsuo M, Muramatsu S, Inokuchi K (2019) Artificial association of memory events by optogenetic stimulation of hippocampal CA3 cell en sembles. Mol Brain 12(1):2. https://doi.org/10.1186 /s13041-018-0424-1
9. Callaghan BL, Li S, Richardson R (2014) The elusive engram: what can infantile amnesia tell us about memory? Trends Neurosci 37(1):47–53. https://doi.org/10.1016/j. Tins.2013.10.007

1. Lehner KR, Silverman HA, Adorissio ME, Roy A, Al-Onaizi MA, Levine Y, et al. Forebrain cholinergic signaling regulates innate immune responses and inflammation. Front Immunol. 2019;10:11.
2. Roy DS, Arons A, Mitchell TI, Pignatelli M, Ryan TJ, Tonegawa S. Memory retrieval by activating engram cells in mouse models of early Alzhei mer’s disease. Nature. 2016;531(7595):508–12.
3. Kim KK, Adhikari A, Deisseroth K. Integration of Optogenetics With Complementary Methodolo gies in Systems Neuroscience. Nat Rev Neurosci. 2017;18(4),222-235. doi:10.1038/nrn.2017.15.
4. Sahel, J.-A. et al. Nature Med. https://www.nature.com/articles/s41591-021-01351-4 (2021).
5. Krook-Magnuson E, Armstrong C, Oijala M, Soltesz I. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat. Commun. 2013; 4: 1376.
6. Tye KM, Mirzabekov JJ, Warden MR et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2013; 493: 537–541.
7. Ahmari SE, Spellman T, Douglass NL et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 2013; 340: 1234–1239.
8. Cardin, J.A., Carle´n, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., Tsai, L.H., and Moore, C.I. (2009). Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459, 663–667.
9. Adamczyk, A.K., Zawadzki, P. The Memory-Modifying Potential of Optogenetics and the Need for Neuroethics. Nanoethics 14, 207–225 (2020). https://doi.org/10.1007/s11569-020-00377-1
10. Ienca, M. (2021). On neurorights. Front. Hum. Neurosci. 15:701258. doi: 10.3389/fnhum.2021.701258 
11. Guevara D and Muñoz JM (2026) Disembodied neurorights? Reconsidering mental integrity and personal identity in memory modification. Front. Psychol. 16:1731892. doi: 10.3389/fpsyg.2025.1731892